CLIENT NEWS
- Rentschler Biopharma SE: Rentschler Biopharma and Leukocare extend service offering with joint U.S. site22 March 2021
- Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease22 March 2021
- RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights18 March 2021
- Lindis Blood Care Initiates Multicenter Clinical EU Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood18 March 2021
- VAXIMM to Participate at Upcoming Scientific and Industry Events18 March 2021
- XPhyto announces European Approval for 25 Minute COVID-19 PCR Test18 March 2021
- ADOCIA Announces its Full Year Financial Results 2020 And Provides Corporate Update18 March 2021
- Newron announces 2020 financial results and provides outlook for 202116 March 2021
- Relief Reports that NeuroRx has Announced Feasibility Collaboration with TFF Pharmaceuticals15 March 2021
- Marinomed Biotech AG Enrolls First Patients in Phase II Clinical Trial of Tacrosolv to Treat Allergic Rhinoconjunctivitis (Hay Fever)11 March 2021